| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
titin | 0.470 | 0.885 | 2.6E-96 |
|
disease | 0.100 | None | 0 | 3 | |||||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.100 | None | 0 | 3 | |||||||||||
|
thyroid peroxidase | 0.455 | 0.846 | 1.8E-21 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
leucine zipper like transcription regulator 1 | 0.547 | 0.808 | 1.0E-92 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ANTXR cell adhesion molecule 2 | 0.568 | 0.808 | 8.7E-02 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
stromal interaction molecule 1 | 0.501 | 0.808 | 0.78 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ubiquitin specific peptidase 7 | 0.538 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
NPC intracellular cholesterol transporter 2 | 0.612 | 0.769 | 1.8E-03 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
dynein cytoplasmic 1 heavy chain 1 | 0.547 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
dual specificity tyrosine phosphorylation regulated kinase 1A | 0.533 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
muscle associated receptor tyrosine kinase | 0.570 | 0.769 | 4.2E-08 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
piezo type mechanosensitive ion channel component 2 | 0.529 | 0.769 | 8.1E-07 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2004 | 2008 | ||||||||
|
collagen type VI alpha 1 chain | 0.587 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
glutamate ionotropic receptor AMPA type subunit 3 | 0.566 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
thyroid hormone receptor interactor 11 | 0.595 | 0.654 | 1.7E-12 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
component of oligomeric golgi complex 4 | 0.631 | 0.615 | 4.0E-09 |
|
disease | 0.100 | None | 0 | 2 |